Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study

Background: Macroscopic vascular invasion (MVI) commonly occurs in patients with advanced hepatocellular carcinoma (HCC) for which resection and sorafenib are the common therapies prescribed. Here, we aimed to compare the survival outcomes of these two therapies in HCC patients with MVI. Methods: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jie, Li, Shao-Hua, Wang, Qiao-Xuan, Lu, Liang-He, Ling, Yi-Hong, Zou, Jing-Wen, Lin, Wen-Ping, Wen, Yu-Hua, Wei, Wei, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214621/
https://www.ncbi.nlm.nih.gov/pubmed/32432036
http://dx.doi.org/10.3389/fonc.2020.00573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214621/
https://www.ncbi.nlm.nih.gov/pubmed/32432036
http://dx.doi.org/10.3389/fonc.2020.00573

Ejemplares similares